20.25
price down icon1.65%   -0.34
after-market After Hours: 20.25
loading

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Forecast

The Kiniksa Pharmaceuticals International Plc (KNSA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $17.15, representing a -15.32% decrease from the current price of $20.25. The highest analyst price target is $19.07, and the lowest is $15.23.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KNSA Price Target
Average 24.24 (+19.69% Upside)
loading

Is Kiniksa Pharmaceuticals International Plc (KNSA) A Buy Now?

Oscillators
Name Value Action
RSI(14) 38.01 Neutral
STOCH(9,6) 25.56 Neutral
STOCHRSI(14) 54.79 Neutral
MACD(12,26) -0.6148 Buy
ADX(14) 32.20 Sell
William %R -80.98 Buy
CCI(14) -48.77 Neutral
Buy: 2 Sell: 1 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
20.52
Sell
20.57
Sell
MA20
21.07
Sell
20.99
Sell
MA50
22.75
Sell
22.14
Sell
MA100
24.04
Sell
22.65
Sell
MA200
21.90
Sell
21.89
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, KNSA could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on KNSA, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 38.01 indicates that KNSA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 25.56 indicates that KNSA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 54.79 indicates that KNSA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 32.2 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -48.77 indicates that KNSA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term KNSA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Kiniksa Pharmaceuticals International Plc financial reports and earnings history, Kiniksa Pharmaceuticals International Plc (KNSA) stock could reach $25.79 by 2030, $28.27 by 2040 and $36.92 by 2050. See the projected annual prices until 2050 of the Kiniksa Pharmaceuticals International Plc stock below:

  • Kiniksa Pharmaceuticals International Plc (KNSA) is expected to reach an average price of $27.11 in 2035, with a high prediction of $27.92 and a low estimate of $25.24. This indicates an $33.85% rise from the last recorded price of $20.25.
  • Kiniksa Pharmaceuticals International Plc (KNSA) stock is projected to chart a bullish course in 2040, with an average price target of $27.01, representing an $33.36% surge from its current level. The forecast ranges from a conservative $26.51 to a sky-high $28.27.
  • Our analysts predict Kiniksa Pharmaceuticals International Plc (KNSA) to jump 72.76% by 2045, soaring from $31.18 to an average price of $34.98, potentially reaching $35.48. While $31.18 is the low estimate, the potential upside is significant.
  • Kiniksa Pharmaceuticals International Plc (KNSA) stock is expected to climb by 2050, reaching an average of $36.62, a $80.86% jump from its current level. However, a wide range of estimates exists, with high and low targets of $36.92 and $34.69, respectively, highlighting the market's uncertainty.

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Year by Year Forecast

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2025

Kiniksa Pharmaceuticals International Plc Stock (KNSA) is expected to reach an average price of $24.24 in 2025, with a high prediction of $33.34 and a low estimate of $15.14. This indicates an +19.69% rise from the last recorded price of $20.25.
Month Average Low High Change from today's price
January, 2025 $16.70 $15.23 $19.07 -17.55%
February, 2025 $19.36 $16.69 $20.56 -4.37%
March, 2025 $22.80 $19.36 $24.17 +12.60%
April, 2025 $20.17 $15.14 $24.61 -0.38%
May, 2025 $23.70 $19.16 $23.85 +17.04%
June, 2025 $26.12 $23.02 $27.43 +28.98%
July, 2025 $29.20 $24.31 $29.88 +44.20%
August, 2025 $26.95 $26.78 $33.34 +33.08%
September, 2025 $24.42 $23.68 $29.20 +20.57%
October, 2025 $20.11 $19.25 $25.21 -0.70%
November, 2025 $20.08 $19.67 $22.70 -0.86%
December, 2025 $20.44 $19.36 $26.01 +0.93%

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2026

The predicted value for Kiniksa Pharmaceuticals International Plc (KNSA) in 2026 is set at an average of $22.94. Estimates vary from a peak of $29.56 to a trough of $16.32, indicating an +13.27% surge from the present price of $20.25.
Month Average Low High Change from today's price
January, 2026 $23.06 $19.34 $23.22 +13.85%
February, 2026 $24.26 $21.50 $25.30 +19.82%
March, 2026 $24.68 $21.48 $25.18 +21.88%
April, 2026 $28.82 $21.68 $29.37 +42.33%
May, 2026 $25.01 $24.62 $29.56 +23.50%
June, 2026 $22.58 $20.59 $25.63 +11.49%
July, 2026 $19.04 $18.68 $22.60 -5.98%
August, 2026 $19.79 $17.92 $20.37 -2.29%
September, 2026 $19.47 $18.44 $20.23 -3.86%
October, 2026 $18.09 $17.60 $21.65 -10.68%
November, 2026 $17.56 $16.50 $18.30 -13.26%
December, 2026 $16.40 $16.32 $18.23 -19.03%

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Kiniksa Pharmaceuticals International Plc (KNSA) is $16.41, with a high forecast of $20.28 and a low forecast of $12.55. This indicates an -18.96% decrease from the last price of $20.25.
Month Average Low High Change from today's price
January, 2027 $15.74 $15.63 $16.88 -22.25%
February, 2027 $17.24 $15.33 $20.28 -14.86%
March, 2027 $18.68 $16.23 $19.28 -7.74%
April, 2027 $16.41 $15.64 $18.83 -18.96%
May, 2027 $15.40 $15.05 $16.96 -23.96%
June, 2027 $14.69 $14.61 $16.76 -27.46%
July, 2027 $15.08 $14.18 $16.41 -25.54%
August, 2027 $15.24 $15.00 $16.64 -24.77%
September, 2027 $13.25 $12.73 $15.56 -34.58%
October, 2027 $14.31 $12.55 $14.37 -29.31%
November, 2027 $16.28 $14.18 $16.86 -19.59%
December, 2027 $17.64 $14.86 $18.98 -12.87%

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2028

In 2028, Kiniksa Pharmaceuticals International Plc (KNSA) is projected to reach an average price of $18.95, with a high projection of $22.51 and a low estimate of $15.40. This indicates an -6.40% fall from the last price of $20.25.
Month Average Low High Change from today's price
January, 2028 $16.69 $16.51 $18.23 -17.57%
February, 2028 $18.11 $15.40 $18.30 -10.57%
March, 2028 $16.71 $16.49 $19.78 -17.48%
April, 2028 $21.07 $17.30 $22.09 +4.04%
May, 2028 $20.79 $19.93 $22.51 +2.67%
June, 2028 $19.40 $19.15 $21.74 -4.21%
July, 2028 $19.26 $18.91 $20.19 -4.91%
August, 2028 $17.38 $17.10 $19.81 -14.18%
September, 2028 $16.12 $15.70 $17.71 -20.42%
October, 2028 $19.11 $15.70 $19.62 -5.62%
November, 2028 $20.05 $18.37 $20.10 -0.96%
December, 2028 $19.54 $19.50 $22.27 -3.49%

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2029

The 2029 price forecast for Kiniksa Pharmaceuticals International Plc Stock (KNSA) is $23.38 on average, with a high prediction of $27.74 and a low estimate of $19.03. This represents an +15.47% increase from the previous price of $20.25.
Month Average Low High Change from today's price
January, 2029 $24.32 $19.03 $26.13 +20.12%
February, 2029 $22.95 $21.71 $24.66 +13.34%
March, 2029 $22.66 $22.11 $23.40 +11.90%
April, 2029 $21.85 $20.77 $23.52 +7.89%
May, 2029 $20.00 $19.68 $22.37 -1.24%
June, 2029 $22.39 $19.74 $22.41 +10.55%
July, 2029 $23.13 $22.05 $24.74 +14.24%
August, 2029 $23.25 $23.19 $25.96 +14.80%
September, 2029 $25.63 $23.14 $26.57 +26.59%
October, 2029 $25.63 $24.81 $27.74 +26.55%
November, 2029 $22.58 $22.23 $25.98 +11.52%
December, 2029 $23.80 $22.55 $25.61 +17.53%

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Price Forecast for 2030

Kiniksa Pharmaceuticals International Plc Stock (KNSA) is expected to reach an average price of $21.63 in 2030, with a high forecast of $29.21 and a low forecast of $14.04. This signifies an +6.80% surge from the last price of $20.25.
Month Average Low High Change from today's price
January, 2030 $22.43 $21.89 $25.79 +10.78%
February, 2030 $22.72 $21.91 $25.65 +12.19%
March, 2030 $20.33 $19.72 $23.40 +0.42%
April, 2030 $17.85 $17.80 $20.66 -11.86%
May, 2030 $17.53 $17.01 $19.45 -13.42%
June, 2030 $15.03 $14.04 $17.56 -25.79%
July, 2030 $18.61 $14.98 $18.66 -8.11%
August, 2030 $22.03 $18.42 $23.62 +8.80%
September, 2030 $23.32 $19.82 $24.77 +15.17%
October, 2030 $26.52 $22.39 $27.98 +30.97%
November, 2030 $24.72 $23.22 $29.21 +22.08%
December, 2030 $26.48 $19.75 $27.49 +30.75%
$11.86
price up icon 1.98%
$91.01
price up icon 1.93%
$84.00
price up icon 0.66%
drug_manufacturers_specialty_generic RDY
$15.49
price up icon 0.78%
$136.99
price up icon 1.16%
$12.49
price down icon 0.24%
Cap:     |  Volume (24h):